COLOSSAL BIO OPPORTUNITIES, LLC filed a Form D with the Securities and Exchange Commission on 2026-09-18.
COLOSSAL BIO OPPORTUNITIES, LLC filed a Form D notice of an exempt securities offering with the SEC on September 18, 2026. The filing reports $2.20M sold. Its industry group is Other Banking and Financial Services. It names David Mehlman (Director) (SEC Form D, September 18, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like COLOSSAL BIO OPPORTUNITIES, LLC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-09-18 · the record
Pitching, partnering or investing alongside them? See who really runs and owns COLOSSAL BIO OPPORTUNITIES, LLC.
Free to see. No signup.
More on the people and the money behind COLOSSAL BIO OPPORTUNITIES, LLC, from the filings we hold.
Other Banking and Financial Services raises by companies based in Delaware, filed in September 2026, largest first.
Get an email when COLOSSAL BIO OPPORTUNITIES, LLC files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when COLOSSAL BIO OPPORTUNITIES, LLC raises, hires or launches. No email unless you switch it on.
Watch COLOSSAL BIO OPPORTUNITIES, LLC →Get the full cited report on COLOSSAL BIO OPPORTUNITIES, LLC
What the filing shows about COLOSSAL BIO OPPORTUNITIES, LLC
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on COLOSSAL BIO OPPORTUNITIES, LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives COLOSSAL BIO OPPORTUNITIES, LLC's address as 251 Little Falls Drive, Wilmington, DE 19808.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on COLOSSAL BIO OPPORTUNITIES, LLC See pricing
COLOSSAL BIO OPPORTUNITIES, LLC is a registered filer with the SEC (CIK 2155938) and has filed since 2026-09-18. 1 filing is on record, the latest on 2026-09-18.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
COLOSSAL BIO OPPORTUNITIES, LLC's Form D of 2026-09-18 names David Mehlman as its officers, directors or promoters.
Its new offerings report $2.20M sold across 1 offering, as its own filings state.
Trailing twelve months. 566 filings in Other Banking and Financial Services, totalled by week. The dot is this raise, $2.20M, on the same scale — one filing against the whole group's total, so it sits low by construction.
David Mehlman is named as Director on the Form D that COLOSSAL BIO OPPORTUNITIES, LLC filed with the SEC on 18 September 2026, the only person that filing names.
1 person named on the filing — 1 as a director only.
Named as of the 2026-09-18 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about COLOSSAL BIO OPPORTUNITIES, LLC
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on COLOSSAL BIO OPPORTUNITIES, LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on COLOSSAL BIO OPPORTUNITIES, LLC covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist COLOSSAL BIO OPPORTUNITIES, LLCYou get an alert in MentionFox the next time this company shows up.
If you're behind COLOSSAL BIO OPPORTUNITIES, LLC: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for COLOSSAL BIO OPPORTUNITIES, LLC. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/colossal-bio-opportunities-llc-form-d-000001